Related Experiment Video
Updated: Jun 19, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
Published on: June 5, 2010
The heart in sporadic inclusion body myositis: a study in 51 patients
Fieke M Cox1, Victoria Delgado, Jan J Verschuuren
1Department of Neurology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC, Leiden, The Netherlands. f.cox@lumc.nl
Insights
Cardiac abnormalities are not more common in sporadic inclusion body myositis (sIBM) patients than expected for their age. Elevated cardiac biomarkers like CK-MB and cTnT are frequent but do not indicate heart disease in sIBM.
Area of Science:
- Cardiology
- Neurology
- Myology
Background:
- Sporadic inclusion body myositis (sIBM) is a rare, progressive neuromuscular disorder.
- Cardiac involvement in sIBM is not well-characterized.
- Understanding cardiac abnormalities in sIBM is crucial for comprehensive patient management.
Purpose of the Study:
- To determine the prevalence and characteristics of cardiac abnormalities in patients with sIBM.
- To investigate the association between cardiac biomarkers and clinical findings in sIBM.
Main Methods:
- Cross-sectional study of 51 sIBM patients.
- Utilized patient history, physical examination, ECG, echocardiography.
- Measured serum creatine kinase activity, CK-MB, cTnT, and cTnI levels.
Main Results:
- 24% of patients had abnormal cardiac history, ECG, or echocardiogram findings.
- Elevated CK-MB (82%) and cTnT (78%) were common, often without acute cardiac pathology.
- Elevated cTnI was rare (2%), and no clear association was found between biomarkers and cardiac abnormalities.
Conclusions:
- Cardiac abnormalities are not significantly more prevalent in sIBM patients than in age-matched controls.
- Elevated CK-MB and cTnT are common in sIBM but do not necessarily indicate cardiac pathology.
- Further research is needed to clarify the significance of these findings in sIBM.
Abstract:
The purpose of this study was to explore the prevalence and nature of cardiac abnormalities in sporadic inclusion body myositis (sIBM). Fifty-one sIBM patients were cross-sectionally studied using history-taking, physical examination, measurements of serum creatine kinase activity, the MB fraction (CK-MB), cardiac troponin T (cTnT) and I (cTnI), a 12-lead electrocardiogram (ECG) and 2-dimensional echocardiography. Present cardiac history was abnormal in 12 (24%) out of 51 patients, 12 (24%) patients had abnormalities on ECG, mostly aspecific, and in 12 (24%) patients the echocardiograph showed abnormalities. Elevated CK-MB was present in 42 (82%) patients and 40 (78%) had an elevated cTnT in the absence of acute cardiac pathology. In contrast, in one patient (2%) cTnI was elevated. There was no apparent association between elevated biomarkers, ECG or echocardiographic abnormalities. The prevalence of cardiac abnormalities in sIBM does not seem to be higher than would be expected in these elderly patients. Elevated CK-MB and cTnT levels are common, in contrast to cTnI, but do not reflect cardiac pathology.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease I: Introduction
Cardiomyopathy I: Introduction and Classification
Pericarditis I: Introduction
